Testing technological innovation and optimizing diagnosis and treatment scenarios--Tarcine's 2023 work summary The annual award ceremony was successfully held

发布时间：2024-03-25 浏览次数：49次 作者：

On March 15, 2024, Tarcine BioMed (Beijing) Inc. held a 2023 year-end summary meeting at the International Conference Center of Zhongguancun Life Science Park. All colleagues of Tarcine attended the meeting.

 

 

Professor Jiao Shoushu, founder of Tarcine, Mr. Li Dongning, president of Baheal Biological Diagnostics, and Dr. Li Quan, general manager of Tarcine, respectively made speeches at the meeting.

 

 

 

 

At the beginning of the meeting, Dr. Li Quan, General Manager of Tarcine, gave a speech on the group's strategic plan for 2024 and the company's work review for 2023, sharing the group's strategic development plan for the new year and clarifying the key work objectives of Tarcine for the next year. Subsequently, the heads of each department of Tarcine shared their work in 2023 and introduced the key work of their department for the year.

 

 

 

 

 

 

 

 

The subsequent award ceremony brought the conference to a climax. The company awarded the "Excellent Suggestion Award" to employees who actively participated in optimization and improvement in 2023, and the "Excellent Employee Award" to employees who participated in the company's key work and achieved excellent results.

 

 

First Prize for Excellent Suggestions - Golden Word Award

 

 

 

First prize for excellent employee（Wu Fan received on behalf of Li Li）

 

 

At the end of the meeting, Dr. Li Quan said that Tarcine would fully implement the goal of "optimizing medical scenarios with technological innovation" of Baheal Pharmaceutical Group in the future, take the responsibility of testing technological innovation and optimizing diagnosis and treatment scenarios, and constantly explore and look forward to contribute to the realization of the overall strategy of the group.